nivolumab
bms
['nivolumab', 'biomarker', 'ca209-76k', 'melanoma', 'nivo', 'bms']
dr. georgina long presenting at #asco2023 "association of biomarkers (bms) with efficacy of adjuvant nivolumab (nivo) vs placebo (pbo) in patients with resected stage iib/c melanoma (ca209-76k)." #melanoma #research 
The Melanoma Research Alliance works to accelerate the pace of scientific discovery & translation. 100% of your donation goes to world-class melanoma research.